NewsMarkets

Science

Nature publishes author correction on METTL1 inhibition study for cancer therapy

The journal Nature has issued an author correction to a recent publication regarding the pharmacological inhibition of METTL1 as a potential treatment for solid and blood cancers.

1 publisher · 1 article · first seen 19 Nov 2026 · updated 3d ago

Headline and summary written by an AI model from the linked article; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 1 article since 19 Nov 2026. Nature published first, on 19 November at 00:00 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Author Correction: Pharmacological inhibition of METTL1 as a therapy against solid and blood cancers Nature ·
Embed this story

Paste this into any web page to show the live odds, with a link back here.